Learning about the features of hidradenitis suppurativa, a skin disease
Follows people with hidradenitis suppurativa to learn about its features.
Key facts
- Who runs it
- University of California, San Francisco
- Where
- San Francisco, United StatesSee the site
- Trial code
- Registry title
- Clinical and Biological Characteristics of Hidradenitis Suppurativa
- Status
- Recruiting
- People taking part
- 1,000 people, planned
- Started
- 15 Jul 2016
- Planned end
- 15 Jul 2026
- Type of study
- Observational, 2 groups
- Record updated
- 4 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with hidradenitis suppurativa (HS), a long-term skin disease, and healthy volunteers. It only observes and collects information and samples.
- Age
- 13 years or older
- Sex
- All sexes
- Disease stage
- Patients: HS diagnosis confirmed by a doctor. Healthy volunteers: no history of long-term skin conditions.
- Earlier treatment
- Healthy volunteers cannot have used antibiotics recently.
Main reasons for not taking part
- Not able to give informed consent, with no parent or guardian able and willing to consent
- Healthy volunteers: any history of long-term skin conditions
- Healthy volunteers: recent antibiotic use
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Age 13 years or older
- Diagnosis of HS clinically-confirmed by a physician
- No history of chronic skin conditions
- No recent history of antibiotic use
Who cannot take part
- Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent; Healthy Volunteer
- Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent
Other criteria
- Hidradenitis Suppurativa Patients
Where in United States
- University of California San FranciscoSan Francisco, United StatesContact: Maia Paul, MPHTaking people
About the trial
What the trial wants to find out
Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.
The 2 groups in the trial
- Hidradenitis Suppurativa Patients
Patients with physician diagnosed Hidradenitis Suppurativa
- Healthy Volunteers
Healthy volunteers without any skin conditions or recent history of antibiotic use.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Clinical and Biological Characteristics of Hidradenitis Suppurativa
- Plain-language title
- Learning about the features of hidradenitis suppurativa, a skin diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 4 May 2026